Page last updated: 2024-09-03

ramatroban and 9-deoxy-delta-9-prostaglandin d2

ramatroban has been researched along with 9-deoxy-delta-9-prostaglandin d2 in 1 studies

Compound Research Comparison

Studies
(ramatroban)
Trials
(ramatroban)
Recent Studies (post-2010)
(ramatroban)
Studies
(9-deoxy-delta-9-prostaglandin d2)
Trials
(9-deoxy-delta-9-prostaglandin d2)
Recent Studies (post-2010) (9-deoxy-delta-9-prostaglandin d2)
1421028283151

Protein Interaction Comparison

ProteinTaxonomyramatroban (IC50)9-deoxy-delta-9-prostaglandin d2 (IC50)
Ubiquitin carboxyl-terminal hydrolase isozyme L3Homo sapiens (human)10

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmad, M; Graham, SH; Hickey, RW; Li, W; Liu, H; Miller, TM; Pascoe, JL; Poloyac, SM; Rose, ME1

Other Studies

1 other study(ies) available for ramatroban and 9-deoxy-delta-9-prostaglandin d2

ArticleYear
Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites.
    Neurotoxicology, 2013, Volume: 39

    Topics: Animals; Apoptosis; Carbazoles; Cells, Cultured; Cerebral Cortex; Cyclopentanes; Dose-Response Relationship, Drug; Embryo, Mammalian; Hypoxia; Intramolecular Oxidoreductases; Lipocalins; Mice; Mice, Knockout; Neurons; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin; Sulfonamides

2013